Tag: Glumetza
Lupin Settles Glumetza Case For $150M
Lupin will pay US$150 million to resolve antitrust litigation over its alleged role in a scheme to delay generic versions of the blockbuster diabetes...
Bausch, Assertio, Lupin To Face Diabetes Drug Glumetza Antitrust Suit
Bausch Health, Assertio Therapeutics and Lupin Pharmaceuticals Inc must face claims by purchasers of Bausch's type 2 diabetes drug Glumetza that they conspired to...
